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The increase in VLDL TAG concentration after ingestion of a high-fructose diet is more pronounced in men than in pre-menopausal women.
We hypothesised that this may be due to a lower fructose-induced stimulation of de novo lipogenesis (DNL) in pre-menopausal women.
To evaluate this hypothesis, nine healthy male and nine healthy female subjects were studied after ingestion of oral loads of fructose enriched
with 13C6 fructose. Incorporation of
13C into breath CO2, plasma glucose and plasma VLDL palmitate was monitored to evaluate total fructose
oxidation, gluconeogenesis and hepatic DNL, respectively. Substrate oxidation was assessed by indirect calorimetry. After 13C fructose ingestion,
44·0 (SD 3·2) % of labelled carbons were recovered in plasma glucose in males v. 41·9 (SD 2·3) % in females (NS), and 42·9 (SD 3·7) % of labelled
carbons were recovered in breath CO2 in males v. 43·0 (SD 4·5) % in females (NS), indicating similar gluconeogenesis from fructose and total
fructose oxidation in males and females. The area under the curve for 13C VLDL palmitate tracer-to-tracee ratio was four times lower in females
(P,0·05), indicating a lower DNL. Furthermore, lipid oxidation was significantly suppressed in males (by 16·4 (SD 5·2), P,0·05), but it was
not suppressed in females (21·3 (SD 4·7) %). These results support the hypothesis that females may be protected against fructose-induced
hypertriglyceridaemia because of a lower stimulation of DNL and a lower suppression of lipid oxidation.
De novo lipogenesis: VLDL TAG: Endogenous glucose production
The metabolic effects of a high-fructose diet have been widely
studied in both animals and human subjects(1). High-fructose
diet is associated with the development of at least two features
of the metabolic syndrome, i.e. insulin resistance and
increased plasma VLDL TAG. The latter may in turn be
associated with an increased production of small, dense
LDL particle with high atherogenic potential(2,3).
It has been reported by several authors that a high-fructose
diet increases plasma TAG less and does not reduce insulin
sensitivity in both pre-menopausal women and female rodents
compared with males(4 – 11). This may be due to a sex-specific
difference in either fructose metabolism or adaptations to
chronic fructose overfeeding. To our knowledge, whether
the metabolism of an acute fructose load differs in females
and males has not been specifically assessed. Fructose disposal
relies mainly on the stimulation of carbohydrate oxidation
(fructose oxidation in splanchnic organs and indirect oxida-
tion of glucose and lactate synthesised from the fructose),
gluconeogenesis, hepatic glycogen storage and hepatic
de novo lipogenesis (DNL). The latter, although a quantitatively
minor pathway for fructose disposal, may be closely linked to
hepatic VLDL TAG production and synthesis of intra-hepatic
lipids. Therefore, we hypothesised that fructose-induced
stimulation of DNL may be blunted in pre-menopausal
women.
To evaluate this hypothesis, we compared the metabolic
fate of ingested fructose in healthy male and female human
subjects. To gain insight into the pathways used for fructose
metabolism, ingested fructose was labelled with 13C6 fructose,
and incorporation of 13C into breath CO2, plasma glucose
and plasma VLDL palmitate was monitored to evaluate
total fructose oxidation, gluconeogenesis and hepatic DNL,
respectively.
Subjects and methods
Subjects
Nine healthy young male (25·1 (SD 5·1) years) and nine
healthy pre-menopausal female (23·8 (SD 4·8) years) subjects
participated in the present study (Table 1). All the subjects
were in apparent good health, had a BMI between 19 and
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25 kg/m2, and were moderately physically active (,3 h/week).
They were non-smokers, and were not taking any medications
at the time of the study. None of the women were on birth
control pills. Female subjects were tested during the follicular
phase (days 1–10) of their menstrual cycle. The present study
was conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures involving human
subjects/patients were approved by the ethical board of
Lausanne University School of Biology and Medicine. Written
informed consent was obtained from all the subjects.
Anthropometric and body composition measurements
At inclusion, standing height was measured using a
stadiometer. Since bioelectric impedance was not available
at the inclusion site, fat mass (FM) and fat-free mass (FFM)
were estimated from the following skinfolds: biceps, triceps,
suprailiac and subscapular(12). All the measurements were
obtained on the right side, with the subject upright and
relaxed. The complete set of measurements was carried out
by a single operator and performed three times. Preparation
of diets, fructose supplementation and the 13C fructose loads
administered during the test were based on these
measurements.
Body composition was measured on the day of the
metabolic test by bioelectrical impedance using the BC-418
eight-contact electrode system (Tanita Corporation, Tokyo,
Japan). FFM and FM were calculated using the manufacturer’s
equations. All the calculations pertaining to the metabolic tests
were done using the value of FFM obtained by bioelectrical
impedance.
Study design and diet
Each subject was studied on one occasion. During the 3 d
preceding the metabolic test, subjects received a standardised,
weight maintenance diet (total energy intake¼ 1·6 times the
resting energy requirements calculated with the equation of
Owen; 15 % proteins, 30 % lipids and 55 % carbohydrate
(simple sugars 10 %)). During this period, all the foods were
provided as pre-packed, weighed portions for each meal.
Three meals and two snacks were provided each day, while
subjects were asked not to consume any other food or drinks
(including alcoholic beverages and coffee).
After this period of controlled diet, subjects were studied
for 2 h in the post-absorptive state (time 2120–0 min) and
over 6 h period after fructose ingestion (time 0–360 min).
Metabolic investigations
Subjects reported at 07.00 hours to the metabolic unit of the
Lausanne University Hospital after a 10 h fast. On arrival,
the subjects were asked to void, and body composition was
estimated by bioelectrical impedance (Tanita Corporation).
Thereafter, they rested on a bed in a semi-recumbent position
until the end of the test. A catheter was inserted into an
antecubital vein for collection of blood samples. The hand
on the same side was kept in a thermostabilised box heated
at 508C to achieve partial arterialisation of venous blood.
Another catheter was inserted into an antecubital vein of the
contralateral forearm for 6,6-2H2-glucose and
2H5-glycerol
infusions. Whole-body glucose and glycerol turnover was
assessed using infusions of 6,6-2H2-glucose (bolus, 2 mg/kg;
continuous, 40mg/kg per min) and 2H5-glycerol (bolus,
0·097 mg/kg; continuous, 0·0097 mg/kg per min). Baseline
blood and breath samples were obtained at time (T)
2120 min for the determination of background isotopic abun-
dances. Thereafter, blood and breath samples were collected
every 30 min for the next 8 h. At times 0, 120 and 240 min,
the subjects ingested a lemon-flavoured drink containing
0·30 g/kg per FFM of fructose enriched with 13C6 fructose at
1·56 625 at% 13C. Energy expenditure and substrate utilisation
were continuously monitored by open circuit indirect calori-
metry (Deltatrac II; Datex Instruments, Helsinski, Finland).
At the end of the study, urine was collected to determine
urea nitrogen excretion rate. No additional foods or liquid,
except water, were permitted during the test day.
Analytical procedures
Blood samples were immediately centrifuged at 48C at
3600 rpm for 10 min, and plasma was stored in aliquots at
2208C. Plasma glucose was measured with the glucose
oxidase method (Glucose Analyser II; Beckman Instruments,
Fullerton, CA, USA). Colorimetric methods were used to
assess plasma concentrations of NEFA (kit obtained from
Wako Chemicals, Freiburg, Germany) and TAG (kit obtained
from Biome´rieux Vitek, Inc., Lyon, France). Commercial RIA
kits were used for the determination of plasma insulin
and glucagon (Linco Research, St Charles, MO, USA).
b-Hydroxybutyric acid and lactate concentrations were
measured enzymatically using the kits obtained from Boehrin-
ger (Mannheim, Germany). Plasma fructose concentrations
were measured by GC–MS; for this purpose, 0·1 ml of
0·55 mM-mannitol was added to 0·2 ml of plasma and
vacuum dried. Thereafter, sugars were acetylated with acetic
anhydride and pyridine overnight, resuspended in 0·2 ml
chloroform and injected into the GC–MS apparatus (Agilent
Technologies, Santa Clara, CA, USA) using a HP-5MS 5 %
phenyl-methyl siloxane column. Analysis was done in electron
impact mode. Ions with m/z 275 and 361 were monitored for
fructose and mannitol, respectively. The ratio of m/z 361/275
was read against a standard curve prepared using pure fruc-
tose(13). Breath 13CO2 isotopic enrichment was determined
by isotope ratio MS on a Tracermass C/N (SerCon Limited,
Table 1. Anthropometric data of subjects at baseline
(Mean values and standard deviations, n 18)*
Males (n 9) Females (n 9)
Baseline, mean SD Baseline, mean SD
Age (years) 25·1 5·1 23·8 4·8
Weight (kg) 73·7 9·0 62·4† 6·1
BMI (kg/m2) 22·1 1·8 22·2 1·3
Fat-free mass (%) 75·4 4·5 68·9† 5·0
Fat mass (%) 24·5 4·5 31·1† 5·1
* Anthropometric data were compared in both sexes using a two-sided Wilcoxon
rank sum test for unpaired values.
† Mean values were significantly different from the corresponding values in male
subjects (P,0·05).
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Crewe, Cheshire, UK). Isotopic enrichments of plasma
6,6-2H2-glucose and
2H5-glycerol were measured by GC–MS
(Agilent Technologies) as described previously(14,15). For the
analysis of plasma 13C glucose, plasma glucose was purified
by sequential anion/cation exchange chromatography using
resins (AG 50 W-X8 and AG 1-X8; Bio-Rad, Richmond,
CA, USA) followed by HPLC(16). Thereafter, 13C abundance
in plasma glucose was analysed by continuous flow-isotope
ratio MS (Roboprep CN-Tracermass; Europa Scientific,
Crewe, UK). Total lipids were extracted from the plasma, and
fatty acid methyl esters were prepared from TAG fractions(17).
The ratio of 13C:13C in the fatty acid methyl ester derivatives
was ascertained using Delta Plus XP GC-combustion ratio
MS (Thermo Electron Corporation, Bremen, Germany). Trico-
sanoic acid methyl ester was used as an isotopic enrichment
standard, and a quality control sample (certified standard of eico-
sanoic acid and fatty acid methyl esters; Department of
Geological Sciences, Indiana University, Bloomington, IN,
USA) was run with each set of samples.
Calculations
Substrate kinetics and 13C glucose appearance. Endogenous
glucose production (EGP), i.e. total rate of glucose appearance
(Ra), was calculated from plasma 6,6-2H2-glucose isotopic
enrichment using the non-steady-state equation of Steele as
modified by De Bodo et al.(18), using a volume of distribution
for glucose of 0·2 times body weight, and a pool fraction
of 0·6. Total Ra glycerol was calculated from plasma
2H5-glycerol isotopic enrichment as described
(19). The contri-
bution of gluconeogenesis from fructose to EGP (EGP (F))
was calculated by monitoring the rate of 13C glucose appear-
ance(20) as follows:
EGP ðFÞ ¼ EGP £ ð13CG2 þ13 CG1Þ=2 þ pV £ ððG1 þ G2Þ=2
£ ðCG2 þ CG1Þ=ðT2 2 T1ÞÞ13CF;
where 13CG is the isotopic enrichment of plasma glucose
(atom percent (AP) excess), G is the glucose concentration,
13CF is the isotopic enrichment of oral fructose (AP excess)
and T is the time. Glucose production from sources other
than fructose (EGP (NF), i.e. from glycogenolysis and
gluconeogenesis from lactate, amino acids and glycerol) was
calculated as follows:
EGP ðNFÞ ¼ EGP2 EGP ðFÞ:
Substrate oxidation and energy expenditure. Net
carbohydrate oxidation rates and net lipid oxidation rates
were calculated from respiratory gas exchanges and urinary
urea nitrogen excretion using the equations of Livesey &
Elia(21). Fructose oxidation was calculated as follows:
13C fructose oxidation ðmg=minÞ
¼ ð13CO2 ðAP%Þ ðtÞ213CO2 ðAP %Þ ðt0Þ=13C Fruct
213CO2 ðAP%Þ ðt0ÞÞ £ ððVCO2 ðtÞ £ 180Þ=ð22·29 £ 6 £ cÞÞ;
where 13CO2 (t) is the value (AP %) of the expired CO2 at
time t, 13CO2 (t0) is the value (AP %) of the expired CO2
at baseline, 13C Fruct is the value (AP %) of the ingested
fructose, VCO2 (l/min) is the average volume that is expired
during the 30 min period, 180 is the molecular weight of
fructose, 1/22·29 is the value used for conversion into moles
of CO2, 1/6 is the value used for conversion into moles of
fructose, c is the CO2 recovery correction factor and chosen
to be 0·8(22).
Non-oxidative fructose disposal (NOFD) was calculated
as follows:
NOFD ðg=kg FFMÞ ¼ fructose load ðg=kg FFMÞ
2 net fructose oxidation ðg=kg FFMÞ:
De novo lipogenesis. The incorporation of 13C fructose
into palmitate of newly synthesised plasma TAG was assessed
by monitoring the enrichment of 13C palmitate in VLDL
TAG. The 13C enrichment results from fatty acid methyl
ester derivatives, expressed as d 13C‰, were converted to
tracer-to-tracee ratio (TTR) using the following equation:
TTR ð13C :12CÞ ¼ ððd13C‰Þ þ 1Þ £ 0·0112372:
The TTR of a baseline measurement, done before
13C-labelled fructose administration, was subtracted from
each sample’s TTR to account for natural abundance(23).
Statistical analysis
All parameters are expressed as means and standard
deviations, except for integrative response of DNL where
parameters are expressed as means with their standard errors.
Post-fructose responses were calculated as incremental area
under the curve (iAUC) using the trapezoidal method
by subtracting the fasting value (Microsoftw Office Excel
2003; Microsoft Corporation, Redmond, WA, USA). Relative
changes in hormone and substrate concentrations after fructose
ingestion were calculated as 100 £ (iAUC/time)/fasting value,
and relative changes in substrate oxidation and glucose and gly-
cerol kinetics after fructose ingestion were calculated as mean
value (T 2 30 2 T0) 2 fasting value/fasting value £ 100.
For each sex, comparisons between fasting and post-fructose
values were assessed using a two-sided Wilcoxon signed rank
test for paired values. The effects of fructose in males v. females
were assessed by comparing the fasting parameters and
integrated post-fructose parameters using a two-sided
Wilcoxon rank sum test for unpaired values. Rates of glycerol
appearance were markedly skewed, and were therefore
log-transformed before statistical analysis. All calculations
were performed with Stata 10 (Stata Corporation, College
Station, TX, USA). Statistical significance was set at P,0·05.
Results
Anthropometric and fasting metabolic parameters
Male and female participants did not differ in age or BMI.
Weight and % FFM were higher, and % FM was lower in
males (P,0·05; Table 1). As shown in Table 2, baseline
glucose, lactate, TAG, b-hydroxybutyrate and insulin were
not significantly different, whereas NEFA tended to be
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lower (P¼0·08). Uric acid and glucagon concentrations
were significantly higher in men (P,0·05).
Plasma hormone and substrate concentrations
The relative changes for fructose, glucose, glucagon, TAG and
NEFA after fructose ingestion were not significantly different
in males v. females, whereas the relative increases for insulin,
lactate and uric acid were higher (P,0·05) in males (Table 3).
De novo lipogenesis
Due to a technical problem with the preparation of the drink
containing fructose enriched with 13C6 fructose during the
first test, only eight male subjects were included for obtaining
the results pertaining to DNL and 13C glucose appearance.
Following fructose ingestion, the 13C enrichment of VLDL
palmitate, expressed as TTR, rose significantly in males, but
remained close to zero in females. The iAUC for VLDL 13C
palmitate was significantly higher in males than in females
(P,0·05; Fig. 1).
Glucose and glycerol kinetics and 13C glucose appearance
Isotopic enrichments of plasma 13C glucose and of 6,6-2H2-
glucose and 2H5-glycerol, which were used for the calculation
of substrate kinetics, are shown in Figs. 2 and 3.
Fasting glycerol Ra tended to be higher in females when
expressed per kg FFM, but it was similar in males and females
when normalised for FM (Fig. 3). Fructose ingestion signifi-
cantly decreased glycerol Ra in males (baseline glycerol
Ra/kg FFM £ min: 3·04 v. 1·94 after fructose ingestion,
P,0·05; Fig. 3), but not in females (3·79 v. 3·19). Suppression
of glycerol Ra expressed as relative decrease over the 6 h
period following fructose ingestion was blunted in females
(241·3 (SD 15·0) in males v. 210·2 (SD 22·9) in females;
Table 3), resulting in higher post-fructose glycerol Ra
(glycerol Ra/kg FFM £ min: 3·19 in females v. 1·94 in
males). When values were normalised for FM, glycerol Ra
was still found to be decreased after fructose ingestion in
males, but not in females.
Fasting glucose Ra, normalised for FFM, was slightly
higher in females than in males (glucose Ra/kg FFM £ min:
2·56 in males v. 3·01 in females, P,0·05; Fig. 5). Following
Table 3. Relative changes in hormone and substrate concentrations
after fructose ingestion, expressed as the percentage of baseline levels
(Mean values and standard deviations, n 18)*
Males (n 9) Females (n 9)
Mean SD Mean SD
Insulin (%) 35·83 24·34 13·26† 12·49
Glucose (%) 5·94 4·22 4·87 7·04
Glucagon (%) 20·68 7·40 20·21 7·13
Lactate (%) 76·27 28·57 36·34† 28·42
Total TAG (%) 25·28 6·63 23·45 9·89
NEFA (%) 232·92 17·61 224·42 12·47
b-Hyroxybutyrate (%) 244·72 28·98 247·54 17·69
Uric acid (%) 3·69 2·40 1·07† 2·00
Fructose (%) 93·32 45·23 72·10 30·63
iAUC, incremental area under the curve.
* The effects of fructose in males v. females were assessed by comparing the
integrated post-fructose parameters using a two-sided Wilcoxon rank sum test
for unpaired values. Relative changes in hormone and substrate concentrations
after fructose ingestion were calculated as 100 £ (iAUC/time)/fasting value.
† Mean values were significantly different from the corresponding values in male
subjects (P,0·05).
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Fig. 1. (a) Mean (SD) time course of the changes in 13C enrichment of VLDL
palmitate in males (X, n 8) and females (W, n 9). (b) Incremental area under
the curve (iAUC) of 13C palmitate tracer-to-tracee ratio (TTR) after ingestion
of fructose in males (B, n 8) and females (A, n 9). Statistical significance is
only indicated in the figure for differences in integrated responses between
males and females. The comparison of iAUC in males v. females was
assessed using a two-sided Wilcoxon rank sum test for unpaired values.
* Mean values were significantly different when compared with males
(P,0·05).
Table 2. Fasting plasma substrate and hormone concentrations of
subjects at baseline
(Mean values and standard deviations, n 18)*
Males (n 9) Females (n 9)
Baseline,
mean SD
Baseline,
mean SD
Insulin (pmol/l) 49·8 11·4 49·8 5·5
Glucose (mmol/l) 4·9 0·4 4·8 0·6
Glucagon (pmol/l) 13·3 1·9 11·8† 0·1
Lactate (mmol/l) 0·8 0·1 0·8 0·2
Total TAG (mmol/l) 0·8 0·1 0·7 0·2
NEFA (mmol/l) 0·5 0·2 0·6 0·2
b-Hyroxybutyrate (mmol/l) 0·1 0·1 0·1 0·1
Uric acid (mmol/l) 345·9 53·0 248·9† 63·3
Fructose (mmol/l) 109·0 6·7 107·9 7·5
* Fasting parameters were compared in both sexes using a two-sided Wilcoxon
rank sum test for unpaired values.
† Mean values were significantly different from the corresponding values in male
subjects (P,0·05).
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fructose ingestion, glucose Ra decreased slightly over time
(Fig. 4). Systemic appearance of 13C glucose, corresponding
to gluconeogenesis from 13C fructose, expressed as EGP (F),
represented 44·01 (SD 3·2) and 41·93 (SD 2·3) % of the total
glucose Ra (NS) in males and females, respectively. Glucose
appearance from sources other than fructose (i.e. correspond-
ing to glycogenolysis and gluconeogenesis from lactate, amino
acids and glycerol), expressed as EGP (NF), was also similar
in both sexes (Fig. 4). Fructose conversion into plasma
glucose, cumulated over 6 h, represented 37·4 (SD 2·1) %
of the ingested fructose in males and 28·86 % (SD 8·1) in
females, P,0·05.
Net carbohydrate and lipid oxidation and energy expenditure
In basal conditions, net carbohydrate oxidation was similar in
both sexes, but net lipid oxidation was higher in females
(P,0·05). Net lipid oxidation following fructose ingestion
was significantly suppressed (net lipid oxidation in mg/kg
FFM £ min: 0·67 after fructose ingestion v. 0·78 at baseline,
P,0·05), whereas net carbohydrate oxidation increased
significantly in males (net carbohydrate oxidation in mg/kg
FFM £ min: 2·26 after fructose ingestion v. 1·80 at baseline,
P,0·05); in females, in contrast, fructose ingestion did not
significantly alter carbohydrate and lipid oxidation (Fig. 5).
Fructose oxidation rate calculated from breath 13CO2 was
similar in both sexes, and accounted for 42·9 (SD 3·7)
and 43·0 (SD 4·5) % of the ingested fructose in males and
females, respectively.
The relative change in energy expenditure after fructose
ingestion, expressed as the percentage of baseline levels,
was higher in males than in females and represented
3·10 (SD 2·21) and 0·06 (SD 2·63) % (P,0·05; Table 4).
The iAUC for RQ was significantly larger in males than in
females (P,0·05; Fig. 6).
Discussion
Fructose oxidation, gluconeogenesis and glycogen storage
(mainly in the liver) are known to be the major pathways of
disposal of an oral fructose load in human subjects(24 – 26).
Of these, total fructose oxidation (including splanchnic fruc-
tose oxidation and indirect peripheral oxidation of glucose)
was assessed by monitoring the rate of 13CO2 production,
and it represented about 43–44 % of the ingested fructose
load, without a difference between males and females.
Conversion of fructose into plasma glucose was also evaluated
by monitoring the systemic appearance of plasma 13C-labelled
glucose, and it was similar in males and females. Finally,
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Fig. 2. Mean (SD) time course of the changes in plasma 6,6-2H2-glucose
(a), 13C glucose (b) and breath 13CO2 (c) after ingestion of fructose in
males (B) and females (W, n 9), except for 13C glucose and breath 13CO2
where the number of males is 8. Fructose oral loads (3 £ 0·30 g/kg fat-free
mass) were ingested at time 0, 120 and 240 min. MR, molar ratio; APE, atom
percent excess.
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Fig. 3. Mean (SD) glycerol rate of appearance (glycerol Ra) normalised for fat-free mass (FFM; a) and fat mass (FM; b) at baseline and after fructose ingestion.
For each sex, comparisons between fasting and post-fructose values were assessed using a two-sided Wilcoxon signed rank test for paired values. * Mean values
were significantly different when compared with baseline (P,0·05). B, Males; A, females.
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glycogen storage was not directly assessed. However, NOFD,
calculated as the difference between the amount of fructose
ingested and net carbohydrate oxidation, is a close approxi-
mation of glycogen synthesis, because net carbohydrate
oxidation would include any fructose conversion into fat(27).
This was not different in males and females. Thus, the quan-
titatively major pathways of fructose disposal were similar
in both sexes.
In previous studies, we and others have reported that
short-term fructose consumption is associated with a
rapid increase in fasting and post-prandial plasma TAG
concentrations(23,28 – 30). Fructose is the most potent lipogenic
substrate in the diet(28,31,32). Although fat synthesis from
fructose is quantitatively minor compared with other pathways
of fructose disposal, it can nonetheless have a profound impact
on plasma and tissue lipids. Fructose ingestion increases
hepatic malonyl-CoA(33), which can increase intra-hepatic
fatty acid availability both directly, by stimulating de novo
fatty acid synthesis, and indirectly, by inhibiting carnitine
palmitoyltransferase-1, and hence intra-hepatic fatty acid oxi-
dation. In a previous study, we have indeed observed that
fractional hepatic DNL was positively correlated with
plasma VLDL TAG concentrations after the ingestion of a
short-term high-fructose diet. Furthermore, inhibition of
DNL by a supplementation with long-chain PUFA of marine
origin led to a proportionate suppression of VLDL TAG(28).
Based on these observations, it appears reasonable to speculate
that fructose-induced DNL is instrumental in eliciting at least
some of the adverse metabolic effects of fructose. This raised
the hypothesis that fructose may stimulate hepatic DNL to a
lesser extent in females than in males. The present results
support this hypothesis. We indeed observed a significant
incorporation of 13C-labelled palmitate in VLDL TAG,
together with a significant suppression of whole-body lipid
oxidation in males, whereas these two effects were conspicu-
ously absent in females. This strongly suggests that females
had less fructose-induced DNL. Moreover, we observed a
much larger increase in the RQ of males after fructose
ingestion, consistent with the suppression of lipid oxidation
and an increased conversion of carbohydrate into fat(27,34).
Differences in fatty acid synthesis between males and females
did not, however, mirror changes in fructose oxidation,
gluconeogenesis or glycogen storage, most likely because
only a small amount of fructose is converted into fatty acids.
In addition to stimulating more DNL in males than in
females, fructose ingestion also differentially affected whole-
body lipid metabolism in males v. females. Fructose ingestion
is known to acutely suppress plasma NEFA and whole-body
lipid oxidation. This is best explained by the significant,
albeit modest stimulation of insulin secretion elicited by
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Fig. 5. Net carbohydrate oxidation (mg/kg FFM £ min) and net lipid oxidation (mg/kg FFM £ min) at baseline and after fructose ingestion. Values are means and
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fructose, which efficiently inhibits adipose tissue lipolysis(35).
Glycerol rate of appearance, which, in the absence of
exogenous fat metabolism, mainly reflects adipose tissue
lipolysis, was more suppressed in males following fructose
ingestion. Although part of the difference may be due to
the physiologically higher body fat content of females, the
glycerol appearance rate normalised for FM remained less
suppressed after fructose ingestion in females. This may be
explained by the somewhat higher (but NS) insulin response
elicited by fructose in males.
The present results point to differences in lipid metabolism
in adipose tissues and in the liver of females compared with
males. The mechanisms involved in this difference have not
been specifically assessed in the present study, and can only
be speculated. Several observations strongly support the
role of oestrogen in this process. Thus, a lesser increase
in plasma TAG after fructose ingestion is observed in
pre-menopausal women, but not in post-menopausal
women(5). In rodents, sex differences in metabolic responses
to fructose can be eliminated by oophorectomy and restored
by oestrogen substitution(6,7). Our observation points to a
dual effect of oestrogens, which stimulate adipose tissue lipo-
lysis while decreasing hepatic DNL. The effect of oestrogen
on adipose tissues has indeed been documented by several
studies: adipocytes from female mice are known to have
increased lipogenic and lipolytic rates compared with those
from male mice(36 – 39). Human in vivo experiments have
also demonstrated that oestrogens increase fatty acid
availability and oxidation(40,41). In post-menopausal patients,
oestrogen replacement therapy reduced the expression of key
genes involved in fatty acid synthesis and fat storage, includ-
ing acetyl-CoA carboxylase, fatty acid synthase and
PPARg(42). Regarding the hepatic effects of oestrogens, to
our knowledge, no data are available in human subjects.
Oestrogen treatment of female rats, however, reduced hepatic
acetyl-CoA carboxylase activity(43). Furthermore, oophorect-
omy decreased the expression of PPARa and increased that
of sterol regulatory element binding protein-1c, and increased
liver TAG content, consistent with a switch towards fat
synthesis upon oestrogen withdrawal(44). Oestrogen treatment
also reversed hepatic steatosis in male rats made deficient
in aromatase(45).
The present study has several limitations which have to be
kept in mind. First, hepatic DNL was qualitatively assessed
by monitoring the incorporation of 13C administered as 13C6
fructose into VLDL palmitate over time. This is a relatively
crude method, which does not allow a quantitative assessment
of fatty acid synthesis due to the absence of steady-state
conditions and of a simultaneous measurement of VLDL
kinetics. Secondly, this method provides an estimate of
fractional hepatic DNL, i.e. the fraction of VLDL palmitate
issued from de novo synthesis; it is therefore possible that
this value was somewhat underestimated in females than in
males due to a higher NEFA flux in females. Finally, the
fructose load administered was normalised for FFM because
the latter is the best predictor of whole-body metabolism.
However, this led to a significantly higher administration of
fructose per kilogram predicted liver weight in males than in
females. This relative hepatic fructose overloading may
explain the higher lactate and uric acid responses in males;
it may also contribute to a more important stimulation of
hepatic DNL in males.
Conclusion
The present data indicate that oral doses of fructose differen-
tially affect hepatic DNL, adipose tissue lipolysis and lipid
oxidation in males and females. This may be due to the effects
of female sex hormone on hepatic and adipose metabolism.
However, it remains to be assessed whether this sex difference
in fructose metabolism confers a significant protection against
the potentially harmful effects of fructose in women.
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